![]() Tanvex BioPharma Tanvex BioPharma (formerly known as Ruenvex Biotech) is a company that manufactures and develops biosimilar and biologic products and drugs. | ![]() FORMA Therapeutics FORMA Therapeutics is a biopharmaceutical company intended for the discovery, development, and commercialization of transformative medicines. | ![]() Calithera Biosciences Calithera Biosciences is a clinical-stage pharmaceutical company focused on discovering and developing novel small molecule drugs directed against tumor metabolism and tumor immunology targets for the treatment of cancer. | ||
Founding Date | Founding Date 2002 | Founding Date 2013 | Founding Date 2008 | Founding Date 2010 |
Type | Type Public | Type Public | Type Public | Type Public |
Tags | ||||
Locations | Locations TW HQ San Diego, US | Locations Taipei, TW HQ New Taipei, TW Irvine, US San Diego, US San Diego, US | Locations Watertown, US HQ | Locations South San Francisco, US HQ |
Employees | Employees 124 | Employees 13827% decrease | Employees 77 | Employees 798% increase |
Valuation ($) | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) 998.7 m | Valuation ($) 29.2 k |
Financial | ||||
Revenue (est.) | Revenue (est.) NT$62.7m (FY, 2024) | Revenue (est.) NT$34.7m (FY, 2024) | Revenue (est.) N/A | Revenue (est.) N/A |
Cost of goods | Cost of goods NT$139m (FY, 2024) | Cost of goods NT$26.4m (FY, 2024) | Cost of goods N/A | Cost of goods N/A |
Gross profit | Gross profit (NT$63.2m) (FY, 2024) | Gross profit NT$8.7m (FY, 2024) | Gross profit N/A | Gross profit N/A |
Net income | Net income (NT$2.5b) (FY, 2024) | Net income (NT$1.4b) (FY, 2024) | Net income ($173m) (FY, 2021) | Net income ($39.7m) (FY, 2022) |
Funding | ||||
Total funding raised | Total funding raised N/A | Total funding raised $ 346.9m | Total funding raised $ 142.5m | Total funding raised $ 105m |
Tanvex BioPharma (formerly known as Ruenvex Biotech) is a company that manufactures and develops biosimilar and biologic products and drugs.
View companyFORMA Therapeutics is a biopharmaceutical company intended for the discovery, development, and commercialization of transformative medicines.
View companyCalithera Biosciences is a clinical-stage pharmaceutical company focused on discovering and developing novel small molecule drugs directed against tumor metabolism and tumor immunology targets for the treatment of cancer.
View company